Citalopram, a selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety, can lead to hair loss in a small subset of users, though it's not common. The effect typically appears weeks to months after starting treatment and may reverse after discontinuation.
SSRIs like citalopram influence neurotransmitter levels in the brain, particularly serotonin. While effective for mood regulation, they can indirectly affect hair follicle cycling. Hair loss linked to citalopram usually presents as diffuse thinning across the scalp rather than patchy bald spots, distinguishing it from autoimmune conditions like alopecia areata.
The U.S. Food and Drug Administration (FDA) lists hair loss as a potential side effect in citalopram's prescribing information, though it occurs in fewer than 1% of patients according to clinical trial data. This low incidence suggests that while causation is possible, it's not a widespread issue.
Normal hair growth follows a cycle: anagen (growth), catagen (transition), and telogen (resting/shedding). Stress-physical or psychological-can push more follicles into the telogen phase prematurely, leading to increased shedding. This condition is known as telogen effluvium.
Citalopram may trigger telogen effluvium through several mechanisms. First, the drug alters neurochemical balance, which can increase physiological stress. Second, changes in hormone levels-such as cortisol or thyroid hormones-may occur as secondary effects. Third, some individuals have genetic predispositions to hair thinning that become unmasked under medication-induced stress.
A 2019 study published in the journal Journal of Clinical Psychiatry analyzed 1,200 patients on SSRIs and found that 0.8% reported noticeable hair thinning, with citalopram among the most frequently cited agents. The onset was typically 4-8 weeks after starting therapy, aligning with the timeline of telogen effluvium.
Not all hair loss from medications is the same. Understanding the pattern helps distinguish citalopram-related thinning from other causes.
| Type | Pattern | Onset | Reversibility |
|---|---|---|---|
| Telogen effluvium | Diffuse thinning, especially at crown | 2-3 months after start | Usually reverses after stopping drug |
| Anagen effluvium | Sudden loss during active growth phase | Days to weeks | Common with chemotherapy, rare with SSRIs |
| Androgenetic alopecia | Receding hairline, thinning temples | Gradual, over years | Not reversed by stopping medication |
Citalopram-associated hair loss falls under telogen effluvium. It's not localized to one area and doesn't form bald patches. Shedding often begins subtly-more strands in the shower drain or on your pillow-and progresses slowly over time.
If hair loss begins around the time you start citalopram, especially within 6-12 weeks, it's reasonable to consider the medication as a contributing factor. However, hair shedding can also stem from unrelated triggers such as illness, surgery, rapid weight loss, or nutrient deficiencies.
One patient I treated in my clinic had begun citalopram for generalized anxiety disorder. After six weeks, she noticed her ponytail felt lighter. A scalp examination showed increased shedding but no inflammation or scarring. After discussing risks and benefits, we decided to switch her to sertraline, which has a lower reported incidence of hair loss. Her hair stabilized within four months.
Important: Hair loss from citalopram is dose-dependent. Higher doses (above 40 mg/day) correlate with slightly higher rates of side effects, including hair thinning. Reducing the dose may help, but never stop abruptly-this can worsen anxiety or trigger withdrawal symptoms.
Many assume that all SSRIs cause hair loss equally. This is incorrect. While citalopram is among the more frequently reported, others like fluoxetine and paroxetine have similar low rates. Sertraline and escitalopram appear to have even lower associations based on pharmacovigilance databases.
Another misconception is that hair loss from citalopram is permanent. In reality, recovery is typical after stopping or switching medication. A 2021 review in Dermatology Online Journal found that 87% of patients who discontinued citalopram due to hair loss saw regrowth within six months.
Also, hair loss from citalopram is not related to its antidepressant efficacy. A patient's response to treatment doesn't predict whether they'll experience shedding. Some people on high doses remain unaffected; others report thinning at low doses.
If hair loss becomes distressing, discuss options with your prescriber. Switching to another SSRI with a lower risk profile-like sertraline-is often effective. Non-SSRI alternatives such as bupropion or mirtazapine may also be considered, depending on diagnosis and comorbidities.
Topical treatments like minoxidil (5%) can support regrowth. A 2020 clinical trial showed that combining minoxidil with SSRI discontinuation led to faster recovery than either intervention alone. However, minoxidil requires consistent use and may cause irritation in some users.
Nutritional support matters too. Deficiencies in iron, vitamin D, or zinc can exacerbate shedding. Blood tests should be done if hair loss persists beyond three months after medication adjustment.
Yes, citalopram can cause hair loss, but it's uncommon and often reversible. Most cases resolve after adjusting dosage or switching medications. If you notice thinning, consult your doctor-not to stop treatment abruptly, but to evaluate the cause and explore alternatives. Hair loss from citalopram is not a reason to discontinue therapy without medical guidance.